Department of Pathology, The Johns Hopkins Hospital, Baltimore, MD.
Department of Pathology, Massachusetts General Hospital, Boston, MA.
J Am Soc Cytopathol. 2024 Jan-Feb;13(1):33-41. doi: 10.1016/j.jasc.2023.10.003. Epub 2023 Oct 19.
Sclerosing Mucoepidermoid Carcinoma with Eosinophilia (SMECE) of the thyroid is an extremely rare tumor that exhibits unique histologic characteristics and is nearly always associated with lymphocytic thyroiditis (LT). However, the cytomorphologic and clinicopathologic characteristics of SMECE have only been described in rare case reports.
Authors' institution laboratory information systems were searched for records of SMECE between 2012 and 2023. Literature review was performed using keywords "Sclerosing mucoepidermoid carcinoma with eosinophilia", "thyroid", and "cytopathology" to search through institution electronic library databases for relevant articles.
A total of 19 cases were identified, 3 unpublished in the authors' archives and 16 in the literature which had fine needle aspiration (FNA) material or cytologic features available for review, and were comprised of 3 males and 16 females. The common cytomorphologic characteristics of SMECE included fragments or loose clusters of intermediate-type epidermoid cells in a background of prominent LT and eosinophils. Overt keratinization, mucinous cells, and extracellular mucin were not commonly encountered, resulting in diagnostic challenges, especially if eosinophils associated with epithelial cell clusters were rare. The cases were reported as "Nondiagnostic" (1 case), "Atypia of Undetermined Significance" (4 cases), "Suspicious for Malignancy" (3 case), or "Malignant" (11 cases).
The clinical course of SMECE of the thyroid varied and distinct cytomorphologic characteristics in a subset of patients who experienced aggressive disease raises the possibility of different prognostic grades. Cases with keratinized squamous cells and necrosis mimic anaplastic (undifferentiated) thyroid carcinoma, but the clinical history and radiologic findings can be helpful to exclude this diagnosis.
甲状腺嗜酸细胞性硬化型黏液表皮样癌(SMECE)是一种极其罕见的肿瘤,具有独特的组织学特征,几乎总是与淋巴细胞性甲状腺炎(LT)相关。然而,SMECE 的细胞形态学和临床病理学特征仅在少数病例报告中有所描述。
作者所在机构的实验室信息系统被搜索了 2012 年至 2023 年间的 SMECE 记录。使用关键词“嗜酸细胞性硬化型黏液表皮样癌”、“甲状腺”和“细胞学”进行文献回顾,通过机构电子图书馆数据库搜索相关文章。
共确定了 19 例病例,其中 3 例未在作者档案中发表,16 例在文献中有细针抽吸(FNA)材料或细胞学特征可供审查,包括 3 名男性和 16 名女性。SMECE 的常见细胞形态学特征包括中间型表皮样细胞的碎片或松散簇,背景为明显的 LT 和嗜酸性粒细胞。明显的角化、黏液细胞和细胞外黏液并不常见,导致诊断挑战,尤其是如果与上皮细胞簇相关的嗜酸性粒细胞较少时。这些病例被报告为“无法诊断”(1 例)、“意义未明的非典型性”(4 例)、“可疑恶性”(3 例)或“恶性”(11 例)。
甲状腺 SMECE 的临床病程不同,在一组经历侵袭性疾病的患者中具有独特的细胞形态学特征,这提示可能存在不同的预后分级。具有角化鳞状细胞和坏死的病例类似于间变性(未分化)甲状腺癌,但临床病史和影像学发现有助于排除这种诊断。